We divided DF patients into 2 groups according to ß-catenin expression and CTNNB1 mutation status — those with ß-catenin expression or CTNNB1 mutations and those without ß-catenin expression and CTNNB1 mutations — and compared clinical features between the groups (S2 Table). This evidence concerns the gene CTNNB1 and dengue disease.